glp 1 gip vs tirzepatide Effects of tirzepatide, a dual and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Compound Tirzepatide

Precursors for NAD+ include: Nicotinamide Mononucleotide (NMN) Nicotinamide Riboside (NR) Nicotinamide (NAM/niacinamide) Nicotinic Acid (NA/niacin) Tryptophan (Trp) Oral supplements for NAD+ precursors are available, but much of their potency is lost during digestion

In clinical trials, people taking the 25mg daily Wegovy pill lost between 14% and 17% of their body weight over 64 weeks, depending on adherence

Semaglutide is a single GLP-1 receptor agonist, while tirzepatide acts on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

The SUMMIT trial below evaluated the effects of tirzepatide in obese patients with HFpEF

As you gain weight, higher levels of these harmful substances end up in your bloodstream, putting you at risk of serious health conditions such as: High blood pressure High cholesterol Type 2 diabetes Heart disease Osteoarthritis Atherosclerosis Obstructive sleep apnea Fatty liver disease Being overweight also increases your chance of developing breast, endometrial, and colon cancers